Ajax Therapeutics
Cambridge
About Ajax Therapeutics
Ajax Therapeutics is an NYC-based biotechnology company applying computational chemistry and structure-based technologies to develop novel small molecules for hematologic malignancies
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $143.0M
- Funding stage: Late Stage Venture
- Last round: Series C (May 2024)
- Website: ajaxtherapeutics.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Life Science, Medical
Canonical: https://fsome.com/organization/ajax-therapeutics-51108 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.